0R2B.L

Danaher Corporation [0R2B.L] Stock Forecast

Q: What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock, located in Washington of Dc and trading under the symbol 0R2B.L

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

0R2B.L Stock Summary

Earnings have grown 6.85% per last year.

EPS has been increasing for the past 3 years (Yearly statements)

Earnings are expected to fall -100% next year

Profit margins (0.2%) are lower than the previous year (0.23%)

0R2B.L's dividend payments are not well covered by cash flows due to its high cash payout ratio (346.04%).

0R2B.L has less than 1 year of cash runway

Top 10 Correlated ETFs

0R2B.L

Top 10 Correlated Stocks

0R2B.L

In the News

0R2B.L Financial details

Company Rating

Strong Buy

Market Cap

155.34B

Income

5.87B

Revenue

29.57B

Book val./share

70.09

Cash/share

16.42

Dividend

Dividend %

13.25%

Employees

79K

Optionable

Shortable

Yes

Earnings

22 Jan 2024

P/E

27.86

Forward P/E

PEG

-39.47

P/S

5.19

P/B

3.12

P/C

13.59

P/FCF

22.64

Quick Ratio

1.77

Current Ratio

2.26

Debt / Equity

0.37

LT Debt / Equity

0.37

EPS (TTM)

7.9

EPS next Y

EPS next Q

EPS this Y

13.65%

EPS next Y

EPS next 5Y

EPS last 5Y

23.3%

Revenue last 5Y

13.04%

Revenue Q/Q

-3.97%

EPS Q/Q

1.34%

SMA20

12.95%

SMA50

-13.83%

SMA100

-8.02%

Inst Own

Inst Trans

ROA

ROE

11%

ROC

0.09%

Gross Margin

59%

Oper. Margin

24%

Profit Margin

20%

Payout

14%

Shs Outstand

700.9M

Shs Float

688.56M

Target Price

52W Range

182.1646-281.3

52W High

-20.56%

52W Low

+22.65%

RSI

Rel Volume

0.04

Avg Volume

31.06K

Volume

1.11K

Perf Week

5.75%

Perf Month

7.97%

Perf Quarter

-7.28%

Perf Half Y

-3.74%

Beta

0.831

Volatility

1.45%, 11.1%

Prev Close

1.98%

Price

223.22

Change

0R2B.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	24.03	24.71	31.01	40.48	42.82
Net income per share	3.39	3.26	4.89	8.5	9.66
Operating cash flow per share	5.67	5.45	8.64	11.49	11.59
Free cash flow per share	4.84	4.57	7.54	9.71	10.02
Cash per share	1.11	27.47	8.4	3.55	8.16
Book value per share	39.76	41.76	55.35	62.07	68.14
Tangible book value per share	-6.53	-3.01	-23.56	-25.91	-13.55
Share holders equity per share	39.76	41.76	55.35	62.07	68.14
Interest debt per share	13.65	29.68	29.5	30.47	25.97
Market cap	73.17B	111.85B	161.17B	239.4B	193.47B
Enterprise value	72.38B	91.94B	155.14B	236.82B	187.48B
P/E ratio	30.41	47.31	45.92	38.72	27.24
Price to sales ratio	4.29	6.24	7.23	8.13	6.15
POCF ratio	18.19	28.3	25.96	28.64	22.71
PFCF ratio	21.28	33.73	29.75	33.89	26.26
P/B Ratio	2.59	3.69	4.05	5.3	3.86
PTB ratio	2.59	3.69	4.05	5.3	3.86
EV to sales	4.25	5.13	6.96	8.04	5.96
Enterprise value over EBITDA	16.96	20.57	23.54	22.91	17.1
EV to operating cash flow	18	23.26	24.99	28.33	22.01
EV to free cash flow	21.05	27.73	28.64	33.52	25.45
Earnings yield	0.03	0.02	0.02	0.03	0.04
Free cash flow yield	0.05	0.03	0.03	0.03	0.04
Debt to equity	0.34	0.71	0.53	0.49	0.38
Debt to assets	0.2	0.35	0.28	0.27	0.23
Net debt to EBITDA	-0.18	-4.45	-0.92	-0.25	-0.55
Current ratio	1.47	5.19	1.86	1.43	1.89
Interest coverage	0	0	0	0	0
Income quality	1.52	1.31	1.7	1.3	1.18
Dividend Yield	0.01	0	0	0	0
Payout ratio	0.18	0.22	0.18	0.12	0.12
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.06	0.06	0.06	0.06	0.06
Intangibles to total assets	0.69	0.52	0.74	0.77	0.71
Capex to operating cash flow	-0.15	-0.16	-0.13	-0.15	-0.14
Capex to revenue	-0.03	-0.04	-0.04	-0.04	-0.04
Capex to depreciation	-0.5	-0.53	-0.45	-0.6	-0.52
Stock based compensation to revenue	0.01	0.01	0.01	0.01	0.01
Graham number	55.08	55.36	78	108.94	121.72
ROIC	0.07	0.05	0.06	0.1	0.11
Return on tangible assets	0.16	0.08	0.18	0.32	0.29
Graham Net	-22.08	-11.9	-36.35	-41.93	-31.23
Working capital	2.25B	20.66B	6.4B	3.51B	7.49B
Tangible asset value	-4.64B	-2.18B	-16.93B	-18.85B	-9.96B
Net current asset value	-12.51B	-6.2B	-22.58B	-26.36B	-18.38B
Invested capital	0.34	0.71	0.53	0.49	0.38
Average receivables	3.32B	3.19B	3.69B	4.41B	4.86B
Average payables	1.5B	1.51B	1.78B	2.31B	2.43B
Average inventory	1.74B	1.63B	1.96B	2.53B	2.94B
Days sales outstanding	66.62	66.6	67.32	58.32	58.08
Days payables outstanding	72.35	69.76	80.93	82.27	66.93
Days of inventory on hand	78.93	74.96	90.53	88.62	90.65
Receivables turnover	5.48	5.48	5.42	6.26	6.28
Payables turnover	5.04	5.23	4.51	4.44	5.45
Inventory turnover	4.62	4.87	4.03	4.12	4.03
ROE	0.09	0.08	0.09	0.14	0.14
Capex per share	-0.82	-0.88	-1.1	-1.78	-1.57

Quarterly Fundamentals Overview

Last date of statement is 2023-09-29 for Q3

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-29
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	10.38	11.22	9.73	9.64	9.19
Net income per share	2.1	2.96	1.94	1.49	1.51
Operating cash flow per share	2.72	3.41	2.64	2.59	2.24
Free cash flow per share	2.35	2.97	2.27	2.14	1.75
Cash per share	6.97	8.04	10.02	11.55	16.42
Book value per share	63.62	67.16	69.89	69.67	70.09
Tangible book value per share	-15.19	-13.36	-11.33	-9.66	-7.39
Share holders equity per share	63.62	67.16	69.89	69.67	70.09
Interest debt per share	25.11	25.59	24.79	24.63	26.1
Market cap	195.7B	196.28B	185.36B	178.19B	186.03B
Enterprise value	190.55B	190.29B	177.98B	169.62B	173.75B
P/E ratio	31.54	22.2	32.43	40.28	41.19
Price to sales ratio	25.54	23.45	25.86	24.9	27.07
POCF ratio	97.36	77.25	95.2	92.52	111.26
PFCF ratio	112.93	88.74	110.86	112.42	142.33
P/B Ratio	4.17	3.92	3.6	3.45	3.55
PTB ratio	4.17	3.92	3.6	3.45	3.55
EV to sales	24.87	22.74	24.83	23.7	25.28
Enterprise value over EBITDA	74.2	66.12	75.64	83.64	86.92
EV to operating cash flow	94.8	74.89	91.41	88.07	103.92
EV to free cash flow	109.95	86.03	106.45	107.01	132.94
Earnings yield	0.01	0.01	0.01	0.01	0.01
Free cash flow yield	0.01	0.01	0.01	0.01	0.01
Debt to equity	0.39	0.38	0.35	0.35	0.37
Debt to assets	0.23	0.23	0.21	0.22	0.22
Net debt to EBITDA	-2.01	-2.08	-3.14	-4.23	-6.14
Current ratio	1.78	1.89	1.89	2.08	2.26
Interest coverage	0	0	0	0	0
Income quality	1.28	1.14	1.34	1.74	1.48
Dividend Yield	0	0	0	0	0
Payout ratio	0.13	0.09	0.14	0.2	0.18
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.05	0.05	0.06	0.06	0.06
Intangibles to total assets	0.72	0.71	0.7	0.69	0.66
Capex to operating cash flow	-0.14	-0.13	-0.14	-0.18	-0.22
Capex to revenue	-0.04	-0.04	-0.04	-0.05	-0.05
Capex to depreciation	-0.51	-0.58	-0.49	-0.61	-0.66
Stock based compensation to revenue	0.01	0.01	0.01	0.02	0.01
Graham number	54.83	66.92	55.23	48.33	48.8
ROIC	0.03	0.03	0.02	0.02	0.02
Return on tangible assets	0.07	0.09	0.06	0.04	0.04
Graham Net	-32.37	-30.78	-28.76	-26.68	-24.52
Working capital	6.25B	7.49B	7.8B	9.06B	11.84B
Tangible asset value	-11.22B	-9.96B	-8.35B	-7.17B	-5.53B
Net current asset value	-19.79B	-18.38B	-17.02B	-15.72B	-14.11B
Invested capital	0.39	0.38	0.35	0.35	0.37
Average receivables	4.55B	4.75B	4.7B	4.34B	4.27B
Average payables	2.31B	2.24B	2.19B	2.02B	1.93B
Average inventory	3.25B	3.17B	3.25B	3.28B	3.1B
Days sales outstanding	52.66	53.86	55.22	53.73	55.84
Days payables outstanding	64.04	60.24	66.96	56.5	59.33
Days of inventory on hand	94.59	81.6	108.86	91.94	94.73
Receivables turnover	1.71	1.67	1.63	1.67	1.61
Payables turnover	1.41	1.49	1.34	1.59	1.52
Inventory turnover	0.95	1.1	0.83	0.98	0.95
ROE	0.03	0.04	0.03	0.02	0.02
Capex per share	-0.38	-0.44	-0.37	-0.46	-0.49

0R2B.L Dividend History

0R2B.L Frequently Asked Questions

What is Danaher Corporation stock symbol ?

Danaher Corporation is a US stock , located in Washington of Dc and trading under the symbol 0R2B.L

What is Danaher Corporation stock quote today ?

Danaher Corporation stock price is $223.22 today.

Is Danaher Corporation stock public?

Yes, Danaher Corporation is a publicly traded company.

Something similar

Top by Market Cap

GAINN

VTSAX

APC.DE

Company Profile

Volume Average 31.06K
Market Capitalization 155.34B
Employee 79K
CEO Mr. Rainer M. Blair
Headquarters Washington,DC,US
IPO Date 2014-11-05
Website https://www.danaher.com

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.